Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Compass Therapeutics
CMPX
$367M
| $1.96M | ﹤0.01% |
365,245
+178,293
| +95% | +$823K |
|
|
AII
4727
American Integrity Insurance
AII
$384M
| $1.96M | ﹤0.01% |
94,087
+75,501
| +406% | +$1.68M |
|
4728
HighPeak Energy
HPK
$811M
| $1.96M | ﹤0.01% |
413,255
+86,922
| +27% | +$522K |
|
4729
Phathom Pharmaceuticals
PHAT
$930M
| $1.95M | ﹤0.01% |
117,781
-137,792
| -54% | -$1.97M |
|
|
EIC
4730
Eagle Point Income Co
EIC
$231M
| $1.95M | ﹤0.01% |
171,227
-37,214
| -18% | -$444K |
|
|
FTMU
4731
Franklin Municipal Income ETF
FTMU
$496M
| $1.95M | ﹤0.01% |
+249,790
| New | +$1.96M |
|
|
ONIT
4732
Onity Group
ONIT
$341M
| $1.95M | ﹤0.01% |
42,504
+12,442
| +41% | +$511K |
|
4733
Puma Biotechnology
PBYI
$406M
| $1.94M | ﹤0.01% |
326,774
-51,308
| -14% | -$272K |
|
|
JHI
4734
John Hancock Investors Trust
JHI
$115M
| $1.94M | ﹤0.01% |
142,132
-5,001
| -3% | -$69K |
|
|
IGI
4735
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.1M
| $1.94M | ﹤0.01% |
117,579
+189
| +0.2% | +$3.13K |
|
|
FSP
4736
Franklin Street Properties
FSP
$50.1M
| $1.93M | ﹤0.01% |
2,043,455
+79,352
| +4% | +$92.2K |
|
4737
Capital Bancorp
CBNK
$615M
| $1.93M | ﹤0.01% |
68,564
+16,054
| +31% | +$461K |
|
|
OLPX
4738
DELISTED
Olaplex Holdings
OLPX
| $1.93M | ﹤0.01% |
1,439,260
+1,025,522
| +248% | +$1.22M |
|
4739
First Trust Alternative Absolute Return Strategy ETF
FAAR
$191M
| $1.93M | ﹤0.01% |
71,059
+70,592
| +15,116% | +$2.1M |
|
4740
Forte Biosciences
FBRX
$1.57B
| $1.92M | ﹤0.01% |
70,531
+70,380
| +46,609% | +$1.23M |
|
4741
Similarweb
SMWB
$630M
| $1.92M | ﹤0.01% |
256,660
-42,868
| -14% | -$346K |
|
|
GRX
4742
Gabelli Healthcare & Wellness Trust
GRX
$143M
| $1.92M | ﹤0.01% |
199,618
+5,658
| +3% | +$53.2K |
|
4743
Fidelity Momentum Factor ETF
FDMO
$915M
| $1.92M | ﹤0.01% |
22,835
-21,136
| -48% | -$1.77M |
|
|
GDO
4744
Western Asset Global Corporate Defined Opportunity Fund
GDO
$77M
| $1.92M | ﹤0.01% |
162,182
+17,718
| +12% | +$208K |
|
|
CRF
4745
Cornerstone Total Return Fund
CRF
$1.14B
| $1.91M | ﹤0.01% |
237,993
-6,478
| -3% | -$51.7K |
|
4746
BondBloxx Bloomberg Two Year Target Duration US Treasury ETF
XTWO
$212M
| $1.91M | ﹤0.01% |
38,531
-31,983
| -45% | -$1.58M |
|
|
NOA
4747
North American Construction
NOA
$370M
| $1.9M | ﹤0.01% |
132,470
+108,634
| +456% | +$1.55M |
|
|
CMRC
4748
Commerce.com Inc Series 1
CMRC
$264M
| $1.9M | ﹤0.01% |
462,008
+230,878
| +100% | +$1.06M |
|
4749
Invesco DB Base Metals Fund
DBB
$305M
| $1.9M | ﹤0.01% |
82,818
+8,972
| +12% | +$195K |
|
4750
Radiant Logistics
RLGT
$411M
| $1.9M | ﹤0.01% |
299,975
+38,507
| +15% | +$239K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.